ATE493434T1 - Immunmodulatorische und gegen tumore wirkende peptide - Google Patents

Immunmodulatorische und gegen tumore wirkende peptide

Info

Publication number
ATE493434T1
ATE493434T1 AT07711100T AT07711100T ATE493434T1 AT E493434 T1 ATE493434 T1 AT E493434T1 AT 07711100 T AT07711100 T AT 07711100T AT 07711100 T AT07711100 T AT 07711100T AT E493434 T1 ATE493434 T1 AT E493434T1
Authority
AT
Austria
Prior art keywords
immunomodulatory
tumor peptides
peptides
tumor
Prior art date
Application number
AT07711100T
Other languages
English (en)
Inventor
Vallespoe Maribel Guerra
Madrazo Isis Torrens
Acosta Osvaldo Reyes
Perez Hilda Garay
Nieto Gerardo Guillen
Castro Boris Acevedo
Gamez Raimundo Ubieta
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE493434T1 publication Critical patent/ATE493434T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07711100T 2006-02-24 2007-02-23 Immunmodulatorische und gegen tumore wirkende peptide ATE493434T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060047A CU23582A1 (es) 2006-02-24 2006-02-24 Péptidos con capacidad anti-tumoral e inmunomoduladora
PCT/CU2007/000006 WO2007095867A1 (es) 2006-02-24 2007-02-23 Peptidos con capacidad anti-tumoral e inmunomoduladora

Publications (1)

Publication Number Publication Date
ATE493434T1 true ATE493434T1 (de) 2011-01-15

Family

ID=38123823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07711100T ATE493434T1 (de) 2006-02-24 2007-02-23 Immunmodulatorische und gegen tumore wirkende peptide

Country Status (16)

Country Link
US (1) US8283324B2 (de)
EP (1) EP1992638B1 (de)
JP (1) JP5069250B2 (de)
KR (1) KR101456205B1 (de)
CN (1) CN101426813B (de)
AR (1) AR059608A1 (de)
AT (1) ATE493434T1 (de)
AU (1) AU2007218671B2 (de)
BR (1) BRPI0708148B1 (de)
CA (1) CA2638828C (de)
CU (1) CU23582A1 (de)
ES (1) ES2358845T3 (de)
MX (1) MX2008010893A (de)
RU (1) RU2430109C2 (de)
WO (1) WO2007095867A1 (de)
ZA (1) ZA200807034B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23674A1 (es) * 2007-07-31 2011-05-27 Ct Ingenieria Genetica Biotech Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
EP2108372A1 (de) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Neue antimikrobielle Peptide
JP5964233B2 (ja) * 2009-09-11 2016-08-03 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダＰｒｏｙｅｃｔｏ Ｄｅ Ｂｉｏｍｅｄｉｃｉｎａ Ｃｉｍａ， Ｓ．Ｌ． Ｈｐｖにより惹起される疾患の治療用組成物
CU23897B1 (es) 2010-05-31 2013-05-31 Ct De Ingeniería Genética Y Biotecnología Péptido para la terapia del cáncer
CN103724412A (zh) * 2013-09-29 2014-04-16 中国科学院海洋研究所 中国明对虾抗脂多糖因子及其制备和应用
US20250382330A1 (en) * 2022-06-29 2025-12-18 Cdres Pharma Llc Immunologically active polypeptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503490A (ja) 1993-08-18 1996-04-16 モルフォシス・ゲゼルシャフト・フュア・プロタインオプティミールング・ミット・ベシュレンクテル・ハフツング リポ多糖結合性および中和能のあるペプチド
CU22700A1 (es) * 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
EP1333847A1 (de) 2000-11-08 2003-08-13 Lorus Therapeutics Inc. Kombinationpräparate enthltend biologische verhaltensändernde stoffe und krebsmittel und ihre verwendung

Also Published As

Publication number Publication date
MX2008010893A (es) 2008-09-03
RU2008137968A (ru) 2010-03-27
JP5069250B2 (ja) 2012-11-07
WO2007095867A1 (es) 2007-08-30
CN101426813A (zh) 2009-05-06
CA2638828C (en) 2014-09-09
RU2430109C2 (ru) 2011-09-27
US8283324B2 (en) 2012-10-09
ZA200807034B (en) 2009-06-24
BRPI0708148B1 (pt) 2019-01-15
US20090221508A1 (en) 2009-09-03
CU23582A1 (es) 2010-10-30
BRPI0708148A2 (pt) 2011-05-17
EP1992638A1 (de) 2008-11-19
CA2638828A1 (en) 2007-08-30
CN101426813B (zh) 2012-04-04
AU2007218671B2 (en) 2012-02-09
JP2009527510A (ja) 2009-07-30
KR101456205B1 (ko) 2014-10-31
AR059608A1 (es) 2008-04-16
KR20080106446A (ko) 2008-12-05
ES2358845T3 (es) 2011-05-16
EP1992638B1 (de) 2010-12-29
AU2007218671A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
DK1988163T3 (da) Hla-a*3303-begrænset wt1 peptid og farmaceutisk sammensætning omfattende det samme
ATE451392T1 (de) Gegen amyloid-beta peptid gerichtete antikörper
ATE534660T1 (de) Peptidsequenzen und zusammensetzungen
GB0712670D0 (en) Isolated peptides and uses thereof
IL199052A0 (en) Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
EP2246064A4 (de) Rekombinantes immunmodulationsprotein (rlz-8) aus ganoderma lucidium und verwendungen davon
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
IL185308A0 (en) Replikin peptides and uses thereof
EP1976864A4 (de) Neues peptid und seine verwendung
IL195525A0 (en) Replikin peptides and uses thereof
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
EP2178903A4 (de) Optimiertes dengue-virus-eintrittshemmendes peptid (dn81)
ZA200807034B (en) Immunomodulatory and anti-tumour peptides
EP1730180A4 (de) Gegen pilze wirkende peptide
EP1893233A4 (de) Therapeutische peptide und impfstoffe
GB0604187D0 (en) Peptide and uses thereof
DE602007011577D1 (de) Immunmodulatorische und gegen tumore wirkende peptide
FI20040655A0 (fi) Proteiini- ja peptidistabilointi
ZA200800566B (en) Therapeutic peptides and vaccines
FI20075483A0 (fi) Uusi peptidi
IL192800A0 (en) Fgf2-binding peptides and uses thereof
IL160376A (en) Arp peptide and uses thereof
PL2227486T3 (pl) Analogi peptydowe i ich koniugaty
GB0521490D0 (en) RFamide-related peptide precursor proteins and RFamide peptides
GB0617564D0 (en) Peptides and methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties